Author(s)

Guobao Wang¹, Fujun Zhang², Sheng Peng², Tao Zhang², Mingjian Lu², Yangkui Gu², Jinhua Huang², Fei Gao^2*

¹Department of Endoscopy and Laser, Sun Yat-Sen University Cancer Center and State Key Laboratory of Oncology in South China, Guangzhou, China.
²Department of Interventional Radiology, Sun Yat-Sen University Cancer Center and State Key Laboratory of Oncology in South China, Guangzhou, China.

The aim was to prospectively evaluate the efficacy and safety of splenic microwave ablation (MWA) combined with transcatheter hepatic arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma (HCC) associated with hypersplenism. Five patients suffering from primary HCC associated with hypersplenism caused by cirrhosis were received MWA combined with TACE. Follow-up examinations included calculation of peripheral blood cells (leukocytes, platelets and red blood cells) and treatment-associated complications. After treatment, leukocyte and platelet counts were significantly higher (P < 0.05) than prior-treatment. Right upper quadrant pain occurred in 3 patients, fever occurred in 4 patients, and mild nausea & vomiting occurred in 3 patients. Complications such as pleural effusion, ascites, bacterial peritonitis, and variceal bleeding did not occur after treatment. So, MWA combined with TACE is effective and safe for the patients with HCC associated with hypersplenism caused by cirrhosis.

Efficacy, Safety, MWA, TACE, HCC, Hypersplenism

Wang, G. , Zhang, F. , Peng, S. , Zhang, T. , Lu, M. , Gu, Y. , Huang, J. and Gao, F. (2015) Effectiveness and Safety of Splenic Micro-wave Ablation Combined with Hepatic Ar-terial Chemoembolization for Hepatocellular Carcinoma Associated with Hypersplenism: A Prospective Study in 5 Patients. Open Journal of Radiology, 5, 72-79. doi: 10.4236/ojrad.2015.52012.